Diagnostic reagent for hepatitis C virus infection
AssigneeSysmex Corporation
InventorsYoichi Takahama, Junichi Shiraishi
Life of this patent
Estimating the term…
Abstract
A diagnostic reagent for hepatitis C virus infection obtained by sensitizing a solid phase with HCV antigen and a conjugated antigen prepared by chemical bonding of HCV antigen and a carrier protein, and a method of diagnosing hepatitis C virus infection, which comprises adding the diagnostic reagent for hepatitis C virus infection to a sample, and measuring the degree of agglutination of carrier particles as the solid phase. The diagnostic reagent and the method of diagnosis enable many samples to be measured with higher sensitivity and rapidity.
Claims12
A diagnostic reagent for hepatitis C virus (HCV) infection comprising a solid phase sensitized with a genetic recombinant HCV antigen and a conjugated HCV antigen which comprises a carrier protein and a synthetic HCV peptide antigen conjugated with the carrier protein, wherein the genetic recombinant HCV antigen having a molecular weight of 10,000 or more, comprises an HCV non-structural region protein and the synthetic HCV peptide antigen having a molecular weight of less than 10,000 comprises an HCV structural region protein.
Dependencies are inferred from the claim text.